Molecular events underlying pregnancy-induced cardiomyopathy
- PMID: 17289564
- DOI: 10.1016/j.cell.2007.01.020
Molecular events underlying pregnancy-induced cardiomyopathy
Abstract
The etiology of cardiomyopathy in pregnant women remains unclear. In this issue, Hilfiker-Kleiner et al. (2007) report that a reduction in STAT3 and a concomitant increase in cathepsin D may be a cause of this disease. Cathepsin D generates an antiangiogenic cleavage product of the hormone prolactin. The authors show that an inhibitor of prolactin secretion may be useful in treating this disease.
Comment on
-
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.Cell. 2007 Feb 9;128(3):589-600. doi: 10.1016/j.cell.2006.12.036. Cell. 2007. PMID: 17289576 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous